Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction

@article{Verbeeck2008PharmacokineticsAD,
  title={Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction},
  author={R. Verbeeck},
  journal={European Journal of Clinical Pharmacology},
  year={2008},
  volume={64},
  pages={1147-1161}
}
  • R. Verbeeck
  • Published 2008
  • Medicine
  • European Journal of Clinical Pharmacology
  • The liver plays a central role in the pharmacokinetics of the majority of drugs. Liver dysfunction may not only reduce the blood/plasma clearance of drugs eliminated by hepatic metabolism or biliary excretion, it can also affect plasma protein binding, which in turn could influence the processes of distribution and elimination. Portal-systemic shunting, which is common in advanced liver cirrhosis, may substantially decrease the presystemic elimination (i.e., first-pass effect) of high… CONTINUE READING
    Pharmacokinetics and dosage adjustment in patients with renal dysfunction
    503
    Analgesics in Patients with Hepatic Impairment
    96
    Drug-related problems and dosage adjustment in patients with liver disease
    A Semi-Mechanistic Model to Predict the Effects of Liver Cirrhosis on Drug Clearance
    129
    Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease
    39
    Variations of pharmacokinetics of drugs in patients with cirrhosis
    10

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 134 REFERENCES
    Hepatic First-pass Metabolism in Liver Disease
    36
    Protein Binding and Kinetics of Drugs in Liver Diseases
    137
    Clinical Pharmacokinetic and Pharmacodynamic Considerations in Patients with Liver Disease
    187
    The effect of liver cirrhosis on the regulation and expression of drug metabolizing enzymes.
    94